{"entity":{"id":"zeria","kind":"company","name":"Zeria Pharmaceutical","aka":["Zeria Pharmaceutical Co., Ltd.","ゼリア新薬工業"],"tldr":"Zeria is a Tokyo pharmaceutical company founded in 1955, strongest in gastroenterology, that sponsors phase 3 cancer trials in Japan.","summary":"Zeria Pharmaceutical Co., Ltd., based in Chūō, Tokyo, and founded in 1955, makes prescription and consumer medicines with a focus on gastrointestinal disease, including bowel preparations used before colonoscopy, and has acted as lead sponsor of phase 3 trials in cancer-related settings registered on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.zeria.co.jp"},{"label":"ClinicalTrials.gov: trials led by Zeria Pharmaceutical Co., Ltd.","url":"https://clinicaltrials.gov/search?lead=Zeria%20Pharmaceutical%20Co.%2C%20Ltd."},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q11314982"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":["colorectal-screening"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Tokyo","country":"JP","companyType":"pharma","website":"http://www.zeria.co.jp","founded":1955,"stage":"public","investors":[],"funding":[]},"route":"/companies/zeria/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"technology":[{"id":"colorectal-screening","kind":"technology","name":"Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood)","route":"/technologies/colorectal-screening/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}